drugset / Trial / NCT02837926

Comparing Health Services Interventions for the Prevention of HPV-related Cancer

NCT02837926

Phase 4 Completed 63 enrolled Reims University Hospital
NaSingle-groupOpen-labelPrevention

Summary

The study aims to identify global and local determinants of HPV vaccine acceptability, HPV vaccine uptake and compliance as well as identify logistics and programmatic issues in each country to offer the HPV vaccine, as a potential cervical cancer prevention strategy, to mid-aged women attending screening.

Timeline

Start
2016-05
Primary completion
2017-12
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cervarix Vaccine
Subject Gardasil Vaccine

Indications